| Abstrakt: |
"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a strain of coronavirus that causes coronavirus disease 2019 (COVID-19), the respiratory illness responsible for the COVID-19 pandemic. Keywords: 2019-nCoV; Amino Acids; Angiotensins; Antibodies; Antigens; Asymptomatic Infection; Autacoids; Biological Factors; Blood Proteins; COVID-19; Coronaviridae; Coronavirus; Enzyme-Linked Immunosorbent Assay; Enzymes and Coenzymes; Epidemiology; Hospitals; Immunoenzyme Techniques; Immunoglobulins; Immunologic Techniques; Immunologic Tests; Immunology; Immunoproteins; Immunosorbent Techniques; Investigative Techniques; Neutralizing Antibodies; Nidovirales; Patent Application; Peptides; Proteins; Public Health; RNA Viruses; Risk and Prevention; SARS-CoV-2; Severe Acute Respiratory Syndrome Coronavirus 2; Viral; Virology EN 2019-nCoV Amino Acids Angiotensins Antibodies Antigens Asymptomatic Infection Autacoids Biological Factors Blood Proteins COVID-19 Coronaviridae Coronavirus Enzyme-Linked Immunosorbent Assay Enzymes and Coenzymes Epidemiology Hospitals Immunoenzyme Techniques Immunoglobulins Immunologic Techniques Immunologic Tests Immunology Immunoproteins Immunosorbent Techniques Investigative Techniques Neutralizing Antibodies Nidovirales Patent Application Peptides Proteins Public Health RNA Viruses Risk and Prevention SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2 Viral Virology 7684 7684 1 09/19/23 20230922 NES 230922 2023 SEP 22 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- A patent application by the inventor Kreutz, Fernando Thome (Porto Alegre, BR), filed on July 13, 2021, was made available online on August 31, 2023, according to news reporting originating from Washington, D.C., by NewsRx correspondents. [Extracted from the article] |
